The Nordic growth exchanges had a mixed market performance, with the small exchanges falling and the large exchanges rising. The fastest rising stock was a Swiss tech company listed in Norway – with a triple-digit increase, similar to the fastest rising stock outside healthcare.
Shares on the Nordic growth exchanges (Kapital Partner Nordic Growth Exchanges Index/ KPNGX) fell 0.3% last week. The major Nordic indices fared better, with the Swedish S30 index up 0.6% and the Danish C25 index up 2.4%.
As expected, the indices are thus in the early stages of recovery, with large caps taking the lead before smaller and riskier stocks, such as growth and biotech companies, see positive price developments.
Since 1 January 2020, the KPNGX index has delivered a negative return of 8%. By comparison, the Swedish S30 index and the Danish C25 index have delivered positive returns of 20-34%. In addition, the S30 index and the C25 index have outperformed the KPNGX index through 2022.
KPNGX index development since 12.31.2020
The 3 best performing stocks on the Nordic growth exchanges last week
Astrocast SA (+187%) operates in the technology sector. The company specializes in the development of IoT networks. The software is self-developed and used primarily to connect networks and machines. Customers consist of corporate clients in a variety of sectors such as agriculture, mining and automotive.
Aino Health AB (111%) is a leading provider of enterprise health management software solutions. The company’s services reduce absenteeism, increase productivity and employee engagement by making health and wellness an integral part of daily work.
Divio Technologies AB (62%) is a technology company. The company is focused on web development with a main focus on offering cloud-based solutions. Customers are found in various industries, with small and medium business customers as the dominant customer base. A large part of the business is based on partnerships with other players at international level.
Share price development of Astrocast SA, Aino Health AB, and Divio Technologies AB year to date
Developments during the week on First North Denmark
The Kapital Partner First North Danmark (KPFNDK) index rose 1.8% last week. The KPFNDK index has underperformed relative to the C25 index by 8% in 2022. However, the KPFNDK index has outperformed most of the smaller equity indices such as the KPNGX index and the TR Venture Capital Index in 2022. However, one explanation is that the KPFNDK index peaked earlier during 2021 than the other indices, as can be seen in the graph below.
Read more: “Strategic review” after the company has risen 13%
KPFNDK index development since 12.31.2020
Developments during the week on First North Denmark at company level
Copyright Agent A/S was the winner of the week after a 59% rise following a voluntary offer by one of the original shareholders – combined with a desire to delist the company. Shape Robotics A/S followed well, up 36%. LED iBOND International A/S was the worst performer, down 14%. Samesystem A/S continues to be the worst performing stock on First North Denmark this year with a 79% drop, while the best performing stock of the year has been Q Interline A/S.
Development on First North Denmark last week and year to date
Read the invesment case for Mdundo A/S that also operates in Africa
Developments during the week for the Nordic healthcare stocks
Nordic healthcare stocks (Kapital Partner Healthcare Index/KPHC) have been hit hard in 2022 with declines of 47%. Last week, however, the KPHC index rose 1.8%, with Aino Health AB (111%), Redsense Medical AB (45%) and Scandion Oncology A/S (39%) making up the top three. Hemcheck Sweden AB fared worst, falling 40%.
KPHC index development since 12.31.2020
Read more: Success leads to launch of next phase
The 3 best performing healthcare stocks in the Nordics last week
Aino Health AB (111%) is a leading provider of enterprise health management software solutions. The company’s services reduce absenteeism, increase productivity and employee engagement by making health and wellness an integral part of daily work.
Redsense Medical AB (+45%) specialises in the development of blood leakage alarms. The products act as sensors based on fibre technology, aiming to detect blood loss faster and alert and report to an installed alarm device. In addition, the company also offers comprehensive packages of needles and catheters.
Scandion Oncology A/S (39%) is a biotechnology company. The company develops drugs for the treatment of cancer containing drug-resistant cell clones. The company’s lead product, SCO-101, has been used in certain standardised cancer treatments during preclinical studies.
Price development of Aino Health AB, Redsense Medical AB and Scandion Oncology year-to-date vs. Kapital Partner Healthcare Index (KPHC)
